Earl R Lewis - Net Worth and Insider Trading

Earl R Lewis Net Worth

The estimated net worth of Earl R Lewis is at least $46 Million dollars as of 2024-11-07. Earl R Lewis is the Director of FLIR Systems Inc and owns about 729,003 shares of FLIR Systems Inc (FLIR) stock worth over $42 Million. Earl R Lewis is the Director of NxStage Medical Inc and owns about 88,145 shares of NxStage Medical Inc (NXTM) stock worth over $3 Million. Earl R Lewis is also the Director of Harvard Bioscience Inc and owns about 467,350 shares of Harvard Bioscience Inc (HBIO) stock worth over $1 Million. Besides these, Earl R Lewis also holds Tecogen Inc (TGEN) , American DG Energy Inc (ADGE) . Details can be seen in Earl R Lewis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Earl R Lewis has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Earl R Lewis

To

Earl R Lewis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Earl R Lewis owns 7 companies in total, including Tecogen Inc (TGEN) , FLIR Systems Inc (FLIR) , and NxStage Medical Inc (NXTM) among others .

Click here to see the complete history of Earl R Lewis’s form 4 insider trades.

Insider Ownership Summary of Earl R Lewis

Ticker Comapny Transaction Date Type of Owner
TGEN Tecogen Inc 2024-07-15 director
FLIR FLIR Systems Inc 2020-11-04 director
NXTM NxStage Medical Inc 2019-02-21 director
LIMIT LIMIT 2017-05-25 director
LIMIT LIMIT 2010-09-02 director
LIMIT LIMIT 2003-03-31 director
LIMIT LIMIT 2003-05-22 director

Earl R Lewis Latest Holdings Summary

Earl R Lewis currently owns a total of 5 stocks. Among these stocks, Earl R Lewis owns 729,003 shares of FLIR Systems Inc (FLIR) as of November 4, 2020, with a value of $42 Million and a weighting of 90.2%. Earl R Lewis owns 88,145 shares of NxStage Medical Inc (NXTM) as of February 12, 2016, with a value of $3 Million and a weighting of 5.72%. Earl R Lewis also owns 467,350 shares of Harvard Bioscience Inc (HBIO) as of May 25, 2017, with a value of $1 Million and a weighting of 2.85%. The other 2 stocks Tecogen Inc (TGEN) , American DG Energy Inc (ADGE) have a combined weighting of 1.22% among all his current holdings.

Latest Holdings of Earl R Lewis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FLIR FLIR Systems Inc 2020-11-04 729,003 57.17 41,677,102
NXTM NxStage Medical Inc 2016-02-12 88,145 30.00 2,644,350
HBIO Harvard Bioscience Inc 2017-05-25 467,350 2.82 1,317,927
TGEN Tecogen Inc 2024-07-15 625,000 0.85 531,250
ADGE American DG Energy Inc 2010-09-02 105,000 0.32 33,285

Holding Weightings of Earl R Lewis


Earl R Lewis Form 4 Trading Tracker

According to the SEC Form 4 filings, Earl R Lewis has made a total of 1 transactions in FLIR Systems Inc (FLIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in FLIR Systems Inc is the sale of 30,000 shares on November 4, 2020, which brought Earl R Lewis around $1 Million.

According to the SEC Form 4 filings, Earl R Lewis has made a total of 0 transactions in NxStage Medical Inc (NXTM) over the past 5 years. The most-recent trade in NxStage Medical Inc is the acquisition of 21,000 shares on February 12, 2016, which cost Earl R Lewis around $307,230.

According to the SEC Form 4 filings, Earl R Lewis has made a total of 0 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years. The most-recent trade in Harvard Bioscience Inc is the acquisition of 12,238 shares on May 25, 2017, which cost Earl R Lewis around $28,759.

More details on Earl R Lewis's insider transactions can be found in the Insider Trading History of Earl R Lewis table.

Insider Trading History of Earl R Lewis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Earl R Lewis Trading Performance

GuruFocus tracks the stock performance after each of Earl R Lewis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Earl R Lewis is 2.69%. GuruFocus also compares Earl R Lewis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Earl R Lewis within 3 months outperforms 11 times out of 28 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Earl R Lewis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Earl R Lewis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 22 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.89 LIMIT LIMIT LIMIT LIMIT LIMIT

Earl R Lewis Ownership Network

Ownership Network List of Earl R Lewis

No Data

Ownership Network Relation of Earl R Lewis

Insider Network Chart

Earl R Lewis Owned Company Details

What does Tecogen Inc do?

Who are the key executives at Tecogen Inc?

Earl R Lewis is the director of Tecogen Inc. Other key executives at Tecogen Inc include director & 10 percent owner & Chief Executive Officer John Hatsopoulos , director & Chief Financial Officer Abinand Rangesh , and 10 percent owner & other: Trustee Pacheco Ann Marie Brown .

Tecogen Inc (TGEN) Insider Trades Summary

Over the past 18 months, Earl R Lewis made 12 insider transaction in Tecogen Inc (TGEN) with a net purchase of 112,652. Other recent insider transactions involving Tecogen Inc (TGEN) include a net purchase of 573,869 shares made by John Hatsopoulos , a net purchase of 2,501 shares made by Abinand Rangesh , and a net purchase of 5,000 shares made by Susan B Hirsch .

In summary, during the past 3 months, insiders sold 0 shares of Tecogen Inc (TGEN) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 0 shares of Tecogen Inc (TGEN) were sold and 694,022 shares were bought by its insiders, resulting in a net purchase of 694,022 shares.

Tecogen Inc (TGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tecogen Inc Insider Transactions

No Available Data

Earl R Lewis Mailing Address

Above is the net worth, insider trading, and ownership report for Earl R Lewis. You might contact Earl R Lewis via mailing address: C/o Nxstage Medical Inc. (nxtm), 439 South Union Street, 5th Floor, Lawrence Ma 01843.